AbCellera Biologics Inc. Share Price
NASDAQ: ABCL | Mid CapAbCellera Biologics Inc. Stock Performance
Open $12.30 | Prev. Close $12.39 | Circuit Range N/A |
Day Range $11.26 - $12.35 | Year Range $2.75 - $12.50 | Volume 3,55,186 |
Average Traded $11.48 |
AbCellera Biologics Inc. Share Price Today
As of 29 August 2026, AbCellera Biologics Inc.'s share price is $11.35. The stock opened at $12.30, compared to its previous close of $12.39. During today's trading session, AbCellera Biologics Inc.'s share price traded between $11.26 and $12.35, with an average price of $11.80. Over the past 52 weeks, the stock has recorded a high of $12.50 and a low of $2.75. In terms of performance, AbCellera Biologics Inc.'s share price has risen by 215.14% over the last six months and is up 172.06% on a year-on-year basis.
AbCellera Biologics Inc. Share Price Chart
AbCellera Biologics Inc. Stock Fundamentals & Key Indicators
Market Cap $3.39B | PE Ratio (TTM) -23.15 | Dividend Yield N/A |
EPS (TTM) $-0.49 | Revenue (TTM) $75.13M | Return On Equity (TTM) -15.14% |
Profit Margin -194.88% | Debt to Equity 0.07 | Quarterly Earnings Growth YoY -11.76% |
AbCellera Biologics Inc. Quarterly Profit & Loss
All figures in USD
AbCellera Biologics Inc. Annual Profit & Loss
All figures in USD
About AbCellera Biologics Inc.
AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its product pipeline includes ABCL635, an antibody-drug candidate, which is in preclinical trial to treat metabolic and endocrine conditions; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in preclinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a research collaboration and license agreement with Eli Lilly and Company; and partnership agreement with Viking Global Investors & ArrowMark Partners and Biogen Inc. AbCellera Biologics Inc. was incorporated in 2012 and is headquartered in Vancouver, Canada.
AbCellera Biologics Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $5.68 | $12.38 | +116.90% |
Jul 2026 | $7.78 | $5.71 | -27.17% |
Jun 2026 | $6.13 | $7.84 | +26.86% |
May 2026 | $4.13 | $6.18 | +48.74% |
Apr 2026 | $3.53 | $4.16 | +18.88% |
Mar 2026 | $3.48 | $3.50 | -2.92% |
Feb 2026 | $3.56 | $3.60 | -0.55% |
Jan 2026 | $3.46 | $3.62 | +6.16% |
Dec 2025 | $3.58 | $3.41 | -8.82% |
Nov 2025 | $5.54 | $3.74 | -32.49% |
Oct 2025 | $5.08 | $5.54 | +10.25% |
Sep 2025 | $4.13 | $5.03 | +20.50% |
ABCL Share Price FAQs
What is AbCellera Biologics Inc. share price today?
What is the 52 week high and 52 week low of AbCellera Biologics Inc. stock?
What is ABCL's market capitalisation today?
What is ABCL's net income for the last quarter?
What is the 5 year returns of ABCL?
What is the high & low stock price of ABCL today?
Can I buy ABCL shares in India?